Andersons pediatric cardiology 1667
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.39 KB, 3 trang )
courseandprognosisofhypertrophic
cardiomyopathyinanoutpatientpopulation.N
EnglJMed.1989;320(12):749–755.
51.CannanCR,ReederGS,BaileyKR,MeltonLJ
3rd,GershBJ.Naturalhistoryofhypertrophic
cardiomyopathy.Apopulation-basedstudy,1976
through1990.Circulation.1995;92(9):2488–
2495.
52.MaronBJ,CaseySA,PoliacLC,etal.Clinical
courseofhypertrophiccardiomyopathyina
regionalUnitedStatescohort.JAMA.
1999;281(7):650–655.
53.MaronBJ,OlivottoI,SpiritoP,etal.
Epidemiologyofhypertrophiccardiomyopathyrelateddeath:revisitedinalargenon-referralbasedpatientpopulation.Circulation.
2000;102(8):858–864.
54.MaronBJ,RowinEJ,CaseySA,etal.
Hypertrophiccardiomyopathyinadulthood
associatedwithlowcardiovascularmortality
withcontemporarymanagementstrategies.JAm
CollCardiol.2015;65(18):1915–1928.
55.SkinnerJR,ManzoorA,HayesAM,JoffeHS,
MartinRP.Aregionalstudyofpresentationand
outcomeofhypertrophiccardiomyopathyin
infants.Heart.1997;77(3):229–233.
56.WilkinsonJD,LoweAM,SalbertBA,etal.
Outcomesinchildrenwithnoonansyndrome
andhypertrophiccardiomyopathy:astudyfrom
thepediatriccardiomyopathyregistry.AmHeart
J.2012;164(3):442–448.
57.AndersenPS,HavndrupO,HougsL,etal.
Diagnosticyield,interpretation,andclinical
utilityofmutationscreeningofsarcomere
encodinggenesinDanishhypertrophic
cardiomyopathypatientsandrelatives.Hum
Mutat.2009;30(3):363–370.
58.AlfaresAA,KellyMA,McDermottG,etal.
Resultsofclinicalgenetictestingof2,912
probandswithhypertrophiccardiomyopathy:
expandedpanelsofferlimitedadditional
sensitivity.GenetMed.2015;17(11):880–888.
59.GrunerC,IvanovJ,CareM,etal.Toronto
hypertrophiccardiomyopathygenotypescorefor
predictionofapositivegenotypeinhypertrophic
cardiomyopathy.CircCardiovascGenet.
2013;6(1):19–26.
60.BosJM,WillML,GershBJ,etal.
Characterizationofaphenotype-basedgenetic
testpredictionscoreforunrelatedpatientswith
hypertrophiccardiomyopathy.MayoClinProc.
2014;89(6):727–737.
61.VanDriestSL,EllsworthEG,OmmenSR,etal.
Prevalenceandspectrumofthinfilament
mutationsinanoutpatientreferralpopulation
withhypertrophiccardiomyopathy.Circulation.
2003;108(4):445–451.
62.LiuW,LiuW,HuD,etal.Mutationspectrumin
alargecohortofunrelatedChinesepatientswith
hypertrophiccardiomyopathy.AmJCardiol.
2013;112(4):585–589.
63.LopesLR,RahmanMS,ElliottPM.Asystematic
reviewandmeta-analysisofgenotype-phenotype
associationsinpatientswithhypertrophic
cardiomyopathycausedbysarcomericprotein
mutations.Heart.2013;99(24):1800–1811.
64.HayashiT,ArimuraT,Itoh-SatohM,etal.Tcap
genemutationsinhypertrophiccardiomyopathy
anddilatedcardiomyopathy.JAmCollCardiol.
2004;44(11):2192–2201.
65.BosJM,PoleyRN,NyM,etal.Genotypephenotyperelationshipsinvolvinghypertrophic
cardiomyopathy-associatedmutationsintitin,
muscleLIMprotein,andtelethonin.MolGenet
Metab.2006;88(1):78–85.
66.GeierC,GehmlichK,EhlerE,etal.Beyondthe
sarcomere:CSRP3mutationscausehypertrophic
cardiomyopathy.HumMolGenet.
2008;17(18):2753–2765.
67.ChiuC,BagnallRD,InglesJ,etal.Mutationsin
alpha-actinin-2causehypertrophic
